DoNatur Overview

  • Founded
  • 1999
  • Status
  • Private
  • Latest Deal Type
  • 2ndary - Private
  • Financing Rounds
  • 2

DoNatur General Information


Developer of anti-rheumatic drugs in different formulations designed to reproduce therapeutic effects from plant extracts. The company's anti-rheumatic drugs helps the consumers by producing drugs to cure rheumatic diseases made from novel active ingredients isolated from medicinal plants of the Danube region in Germany.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Am Klopferspitz 19
  • Martinsried
  • 82152 Munich
  • Germany
+49 089 00000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DoNatur Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore DoNatur‘s full profile, request access.

Request a free trial

DoNatur Executive Team (1)

Name Title Board Seat Contact Info
Franz Kerek Founder & Chief Executive Officer
To view DoNatur’s complete executive team members history, request access »